CATL stock price in focus before China open after share-swap deal surfaces
8 February 2026
1 min read

CATL stock price in focus before China open after share-swap deal surfaces

Shanghai, Feb 9, 2026, 04:35 CST — Premarket

  • CATL’s Class A stock wrapped up trading 1.7% higher at 369.11 yuan.
  • A battery-chemicals company with a public listing is set to acquire a stake owned by CATL, using a share issue that will bring CATL onto its shareholder register.
  • Investors have their eyes on the transaction details, along with CATL’s next results announcement lined up for March.

Contemporary Amperex Technology Co., Limited Class A (300750.SZ) is drawing attention before Monday’s session, with a weekend filing revealing a fresh equity-linked deal tied to China’s battery materials sector.

CATL finished Friday at 369.11 yuan, gaining 1.7%. Shares are holding close to the top of their recent band, with investors eyeing new deal risk into next week. (Yahoo Finance)

Why it matters now: this isn’t your typical cash deal. Instead, CATL would exchange its upstream stake for fresh shares, changing up control dynamics—and the timing—while sidestepping an upfront cash outlay.

Yongtai Technology is looking to acquire a 25% stake in Shaowu Yongtai Gaoxin Materials from CATL by issuing new shares, with a related fundraising in the works. Once the deal goes through, CATL will take a stake in Yongtai Technology. The company announced its shares will be suspended starting Feb. 9 when the market opens. (Eastmoney Finance)

Yongtai announced it has a letter of intent in place with CATL, but specifics like pricing and lock-up periods are still to be hammered out in future contracts. The company says a fuller plan should be released within the next 10 trading days; if not, shares will start trading again and negotiations will be called off. (NBD)

CATL holders now face a choice: Is this just a slight reshuffling, or does it hint at the battery titan repositioning inside the materials stack?

The unit up for grabs produces key battery ingredients like lithium hexafluorophosphate and lithium bis(fluorosulfonyl)imide—both are integral to electrolytes, which move charge within a battery. (Eastmoney Finance)

Timing could play a part here. Details on the deal remain sparse, so traders might hold back from jumping in when the market opens. Still, a fresh disclosure has the potential to reshape how investors view capital allocation and the upstream strategy.

Here’s the risk: this is just a plan for now. Key details like pricing, regulatory signoff, and how settlement will work remain under wraps. Should negotiations falter or final terms fall short, investors could easily tag the deal as non-core — or start fretting about mark-to-market volatility if CATL winds up sitting on shares in the listed acquirer.

Investors, having digested the deal, are now eyeing CATL’s next results on March 21—a key date that should bring the first concrete look at margins and demand heading into 2026. (Investing.com)

Looking ahead, the immediate focus turns to the buyer’s transaction plan disclosure window—as well as any comments from CATL. Trading will pick back up either when the suspension ends or after the plan goes public.

Stock Market Today

  • Netskope (NTSK) Share Price Slump: Is the Stock Overvalued Despite Recent Declines?
    February 8, 2026, 5:12 PM EST. Netskope's share price fell 19.1% in the past week, 27.8% in 30 days, and is down 28.9% year to date. Despite the decline, a Discounted Cash Flow (DCF) analysis shows the stock is trading at a 71.3% premium over its estimated intrinsic value of $7.01 per share, suggesting overvaluation. The company scores just 1 out of 6 on valuation checks, indicating potential risk. Netskope operates in cybersecurity and cloud software, sectors sensitive to growth and profitability expectations. Investors should consider these factors amid shifting risk sentiment and fluctuating investor confidence.

Latest article

Amgen stock jumps to a 52-week high; here’s what to watch before Monday’s open

Amgen stock jumps to a 52-week high; here’s what to watch before Monday’s open

8 February 2026
Amgen shares jumped 4.49% to $384.32 Friday, hitting a 52-week high as the Dow closed above 50,000 for the first time. The move followed strong quarterly results and a $2.52 per share dividend declaration. CVS Caremark will drop Amgen’s Prolia from some preferred lists in April, citing biosimilar competition. Investors await next week’s delayed U.S. jobs and inflation data.

Popular

Waaree Energies Share Price Today (8 December 2025): Emkay’s 48% Upside Call, Fresh Orders and Tariff Risks Explained

Waaree Energies Share Price Today (8 December 2025): Emkay’s 48% Upside Call, Fresh Orders and Tariff Risks Explained

8 December 2025
Waaree Energies traded near ₹2,894 on the NSE by late morning 8 December 2025, up 0.7% intraday but down nearly 10% over five sessions. Emkay Global initiated coverage with a ‘Buy’ and a ₹4,260 March 2027 target, citing strong growth forecasts and expansion plans. The stock’s market cap stands at about ₹83,000 crore. Eight analysts cover the stock, with mixed recommendations.
Intel stock jumps nearly 5% as China server CPU squeeze hits — what to watch next week
Previous Story

Intel stock jumps nearly 5% as China server CPU squeeze hits — what to watch next week

UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next
Next Story

UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next

Go toTop